Congress Trades

Coverage gap. Senate eFD: the last 15 checks failed; last successful check Oct 23. New filings from this source are not coming in. Newest Senate eFD filing on this site: 2026-10-21.

Source status

Jeffrey M LeidenFiled

Executive ChairmanExecutiveDirectorCIK 1242825
Net · 12 months
-$60.9M
Open-market buys − sales
Sold · 12 months
$60.9M
$0 in 90d · 24 sales on record
Bought · 12 months
$0
$0 in 90d · 0 buys on record
Under 10b5-1
100%
Share of sale value under a trading plan
Last trade
Feb 24, 2026
Filed Feb 26, 2026 · 48 rows

Monthly open-market value · 24 months Filed

  • Bought (open market)
  • Sold (open market)

Unusual activity Estimated

Whale score 95Whale watch
  • 27Exec salePublic Dec 5, 2025 · traded Dec 3, 2025

    VRTX Chair Jeffrey M Leiden sold $7.1M (10b5-1 plan)

    Details
    Insider
    Jeffrey M Leiden
    Company
    VERTEX PHARMACEUTICALS INC / MA
    Ticker
    VRTX
    Tx kind
    open_market_sale
    Traded
    Dec 3, 2025
    Shares
    15,681
    Price
    $452
    Value
    $7.1M
    Is 10b5 1
    Yes
    Filed
    Dec 5, 2025
    Public from
    Dec 5, 2025
    Method version
    2026-11-03
  • 32Exec salePublic Nov 17, 2025 · traded Nov 14, 2025

    VRTX Chair Jeffrey M Leiden sold $14.2M (10b5-1 plan)

    Details
    Insider
    Jeffrey M Leiden
    Company
    VERTEX PHARMACEUTICALS INC / MA
    Ticker
    VRTX
    Tx kind
    open_market_sale
    Traded
    Nov 14, 2025
    Shares
    32,234
    Price
    $440
    Value
    $14.2M
    Is 10b5 1
    Yes
    Filed
    Nov 17, 2025
    Public from
    Nov 17, 2025
    Method version
    2026-11-03
  • 29Exec salePublic Nov 17, 2025 · traded Nov 14, 2025

    VRTX Chair Jeffrey M Leiden sold $9.4M (10b5-1 plan)

    Details
    Insider
    Jeffrey M Leiden
    Company
    VERTEX PHARMACEUTICALS INC / MA
    Ticker
    VRTX
    Tx kind
    open_market_sale
    Traded
    Nov 14, 2025
    Shares
    21,330
    Price
    $441
    Value
    $9.4M
    Is 10b5 1
    Yes
    Filed
    Nov 17, 2025
    Public from
    Nov 17, 2025
    Method version
    2026-11-03
  • 28Exec salePublic Nov 17, 2025 · traded Nov 13, 2025

    VRTX Chair Jeffrey M Leiden sold $8.2M (10b5-1 plan)

    Details
    Insider
    Jeffrey M Leiden
    Company
    VERTEX PHARMACEUTICALS INC / MA
    Ticker
    VRTX
    Tx kind
    open_market_sale
    Traded
    Nov 13, 2025
    Shares
    18,528
    Price
    $440
    Value
    $8.2M
    Is 10b5 1
    Yes
    Filed
    Nov 17, 2025
    Public from
    Nov 17, 2025
    Method version
    2026-11-03

Transactions

Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.